The drug retailer’s AB Health Ventures unit will focus on early to mid-stage healthcare technology providers working on areas including pharmaceutical distribution, commercialisation and pet care.
US-based pharmaceutical wholesaler AmerisourceBergen formed a $150m corporate venture capital (CVC) subsidiary dubbed AB Health Ventures yesterday that will target healthcare technology developers.
Formed by a 2001 merger between pharmaceutical and health product distributors AmeriSource Health Corporation and Bergen Brunswig Corporation, AmerisourceBergen distributes healthcare products to manufacturers, pharmacies and providers and has some 42,000 employees globally.
AB Health Ventures will back healthtech entrepreneurial projects at early to mid-stage, focusing on innovative products and services related to pharmaceutical distribution, clinical development,…
